Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report.

about

Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report.

Item

http://www.wikidata.org/entity/Q55489012

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Itraconazole treatment of prim ...... DNA microarray: a case report.

@en

Itraconazole treatment of prim ...... DNA microarray: a case report.

@nl

type

Item

label

Itraconazole treatment of prim ...... DNA microarray: a case report.

@en

Itraconazole treatment of prim ...... DNA microarray: a case report.

@nl

prefLabel

Itraconazole treatment of prim ...... DNA microarray: a case report.

@en

Itraconazole treatment of prim ...... DNA microarray: a case report.

@nl

P1476

Itraconazole treatment of prim ...... DNA microarray: a case report.

@en

P2093

Hiroshi Tsubamoto

http://www.w3.org/2001/XMLSchema#string

Kayo Inoue

http://www.w3.org/2001/XMLSchema#string

Kazuko Sakata

http://www.w3.org/2001/XMLSchema#string

Nami Nakagomi

http://www.w3.org/2001/XMLSchema#string

Roze Isono-Nakata

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients.

Characterization of serum biomarkers for detection of early stage ovarian cancer.

Impact of Itraconazole After First-line Chemotherapy on Survival of Patients with Metastatic Biliary Tract Cancer.

Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity.

Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways

Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.

Primary malignant melanoma of the vagina.

Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.

P2888

s12885-018-4520-5

P304

630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S12885-018-4520-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104385396

http://www.w3.org/2001/XMLSchema#string

P698

29866134

http://www.w3.org/2001/XMLSchema#string

P932

5987480

http://www.w3.org/2001/XMLSchema#string